ARCHIVES

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

This article is from The Cancer Letter archive.

Vol. 10 No. 14 | April 6, 1984

Download PDF Visit The Full Archive

Related Articles

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Natcher Subcommittee Kills Recision, Save NCI $17 Million

May 2, 1980

NTP Plans Look At Radiation, Viruses, In Carcinogen Report.

July 27, 2001

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

June 4, 1999

NCI CTEP Approved Trials For the Month of July

July 26, 2013

In Brief: Gusberg Heads ACS, With Scanlon As President Elect; MDA honors Holland, D’Angio, Landing

November 16, 1979